SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-15-000654
Filing Date
2015-04-06
Accepted
2015-04-06 13:58:54
Documents
12
Period of Report
2015-04-06

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v406530_6k.htm 6-K 12466
2 EXHIBIT 1.1 v406530_ex1-1.htm EX-1.1 189216
3 EXHIBIT 5.1 v406530_ex5-1.htm EX-5.1 17117
4 EXHIBIT 8.1 v406530_ex8-1.htm EX-8.1 12892
5 EXHIBIT 23.1 v406530_ex23-1.htm EX-23.1 7686
6 GRAPHIC image_002.jpg GRAPHIC 2120
7 GRAPHIC image_003.jpg GRAPHIC 12966
8 GRAPHIC image_004.jpg GRAPHIC 24027
9 GRAPHIC image_005.jpg GRAPHIC 7581
10 GRAPHIC image_006.jpg GRAPHIC 4279
11 GRAPHIC image_007.jpg GRAPHIC 23715
12 GRAPHIC image_008.jpg GRAPHIC 23722
  Complete submission text file 0001279569-15-000654.txt   377317
Mailing Address 5955 AIRPORT ROAD, SUITE 228 MISSISSAUGA A6 L4V 1R9
Business Address 5955 AIRPORT ROAD, SUITE 228 . MISSISSAUGA A6 L4V 1R9 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 15753134
SIC: 2836 Biological Products, (No Diagnostic Substances)